TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

Gopa Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.